CATEGORY: CELL & GENE THERAPY
The results are in! We are pleased to announce the winners of the 2021 BPI Readers' Choice Awards.
This year's nominees in the Readers' Choice Cell and Gene Therapy category represent the latest advances in moving this technology into the manufacturing space. Apte et al. explore factors that continue to complicate CGT manufacturing, then highlight regulatory pathways that could help therapy developers to fast-track their products to the market. Bream and Salzmann present findings from a survey of 150 biopharmaceutical industry leaders concerning CGT facility requirements and preparations for increasing production capabilities. Goldberg overviews analytical performance characteristics that must be considered during development and validation of assays for cell therapy products. And Jin describes how Droplet Digital polymerase chain reaction (ddPCR) assays can be used to track and quantify chimeric antigen receptor (CAR) gene sequences in transduced T cells.
BPI's congratulations go out to all the nominees this year — and especially to the winner and runners-up highlighted in this eBook.
